Protagonist Therapeutics (PTGX) Work In Process: 2021-2024
Historic Work In Process for Protagonist Therapeutics (PTGX) over the last 1 years, with Dec 2024 value amounting to $165.0 million.
- Protagonist Therapeutics' Work In Process rose 1550.00% to $165.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $165.0 million, marking a year-over-year increase of 1550.00%. This contributed to the annual value of $165.0 million for FY2024, which is 1550.00% up from last year.
- According to the latest figures from Q4 2024, Protagonist Therapeutics' Work In Process is $165.0 million, which was up 383,620.93% from $43,000 recorded in Q2 2024.
- Protagonist Therapeutics' 5-year Work In Process high stood at $300.0 million for Q1 2024, and its period low was $10,000 during Q4 2022.
- In the last 3 years, Protagonist Therapeutics' Work In Process had a median value of $5.1 million in 2022 and averaged $79.2 million.
- Per our database at Business Quant, Protagonist Therapeutics' Work In Process plummeted by 99.36% in 2022 and then skyrocketed by 99,900.00% in 2023.
- Protagonist Therapeutics' Work In Process (Quarterly) stood at $1.6 million in 2021, then tumbled by 99.36% to $10,000 in 2022, then spiked by 99,900.00% to $10.0 million in 2023, then surged by 1,550.00% to $165.0 million in 2024.
- Its Work In Process stands at $165.0 million for Q4 2024, versus $43,000 for Q2 2024 and $300.0 million for Q1 2024.